Clinical Trial Update: Apatinib With Albumin-bound Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial updating apatinib with albumin-bound paclitaxel in platinum-resistant recurrent ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Albumin-bound paclitaxel (nab-paclitaxel)
• Apatinib (apatinib)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Ovarian Cancer | Phase 2 | Status: UNKNOWN